Arcadia Biosciences, Inc.
Consumer Defensive sector | Packaged Foods industry
Metrics for RKDA
| Price | $0.78 |
|---|---|
| Shares Outstanding | 2.06M |
| All-Time Low | $1.66 |
| 52-Week Low | $1.66 |
Balance Statement Metrics
| Net Cash / Share | $0.62 |
|---|---|
| Net Current Assets / Share | $1.33 |
| Net Tangible Assets / Share | $1.38 |
| Shares Outstanding Ave Change (Annual) | 35.01% |
| Shares Δ YoY | 6.19% |
| Avg CA Burn (Annual %) | -35.85% (as of 5-24-2026) |
| Avg CA Burn (Quarterly %) | -11.64% (as of 5-24-2026) |
Earning Metrics
| Max Earning Power / Share | $-3.57 |
|---|---|
| Adjusted Earning Power |
$-20.3
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
0.38%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 5-24-2026) |
| Avg EBITDA (5Q) | 0 (as of 5-24-2026) |
| Avg Net Income (5Y) | -12.8M (as of 5-24-2026) |
| Avg Net Income (5Q) | -1.3M (as of 5-24-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 5-24-2026 |
| Consecutive Years Paid | No | 5-24-2026 |
| Pays Dividend | No | 5-24-2026 |
| Last Dividend Date | 1-23-18 | |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 5-24-2026 |
| Net Income Positive | No | 5-24-2026 |
| Current Dividend Streak | No | 5-24-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 7 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2026-03-31 | Quarterly | $1.38 | 2.8M ($2,846,000) | 2.1M (2,056,884) |
| 2025-12-31 | Quarterly | $2.99 | 4.1M ($4,101,000) | 1.4M (1,373,120) |
| 2025-09-30 | Quarterly | $3.95 | 5.4M ($5,404,000) | 1.4M (1,367,429) |
| 2025-06-30 | Quarterly | $3.29 | 4.5M ($4,494,000) | 1.4M (1,367,040) |
| 2025-03-31 | Quarterly | $6.49 | 8.9M ($8,866,000) | 1.4M (1,367,040) |
| 2024-12-31 | Quarterly | $4.53 | 6.2M ($6,184,000) | 1.4M (1,364,940) |
| 2024-12-31 | Annual | $4.53 | 6.2M ($6,184,000) | 1.4M (1,364,940) |
| 2024-09-30 | Quarterly | $7.51 | 10.2M ($10,248,000) | 1.4M (1,364,940) |
| 2023-12-31 | Annual | $9.96 | 12.8M ($12,802,000) | 1.3M (1,285,337) |
| 2022-12-31 | Annual | $34.08 | 21M ($20,993,000) | 616.1K (616,079) |
| 2021-12-31 | Annual | $55.19 | 30.6M ($30,609,000) | 554.6K (554,605) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 5M ($5,045,000) |
| 2023-12-31 | 4.5M ($4,454,000) |
| 2022-12-31 | 7.4M ($7,418,000) |
| 2021-12-31 | 6.8M ($6,780,000) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-04-02 | 2,056,884 | +327,000 |
| 2026-01-30 | 1,729,884 | -451,831 |
| 2026-01-15 | 2,181,715 | +808,595 |
| 2025-11-14 | 1,373,120 | +6,080 |
Short Interest Changes
Latest short-interest change: 411,143 shares (20.02% of float) | Days to cover: 0.14
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-06-10 | 411,143 shares | +402,061 | +4427.01% |
| 2026-05-28 | 9,082 shares | +2,743 | +43.27% |
| 2026-05-12 | 6,339 shares | +4,744 | +297.43% |
| 2026-04-27 | 1,595 shares | +668 | +72.06% |
| 2026-04-17 | 927 shares | -22,765 | -96.09% |
| 2026-03-24 | 23,692 shares | +7,385 | +45.29% |
| 2026-03-12 | 16,307 shares | +452 | +2.85% |
| 2026-02-27 | 15,855 shares | +4,950 | +45.39% |
| 2026-02-11 | 10,905 shares | +1,717 | +18.69% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| 2026-06-15 | 555,550 | 2,056,884 | 27.01% | $0.92 |
| 2026-06-12 | 2,583,524 | 2,056,884 | 125.60% | $1.03 |
| 2026-06-11 | 116,270,718 | 2,056,884 | 5652.76% | $1.07 |
| 2026-05-22 | 578,285 | 2,056,884 | 28.11% | $0.92 |
| 2026-05-21 | 1,180,143 | 2,056,884 | 57.38% | $0.91 |
| 2026-05-20 | 59,367,547 | 2,056,884 | 2886.29% | $0.95 |
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.